BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35937020)

  • 1. Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
    Kefi A; Jaziri F; Ben Abdelghani K; Turki S
    Clin Case Rep; 2022 Aug; 10(8):e6122. PubMed ID: 35937020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
    Wang SS; Chen QY; Xiang LH
    Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dermato-neuro syndrome-an acute and life-threatening complication of scleromyxedema Arndt-Gottron].
    Linse KP; Enk A; Hoffmann J
    Dermatologie (Heidelb); 2023 Aug; 74(8):618-620. PubMed ID: 37284981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of intravenous immunoglobulin in Arndt-Gottron scleromyxedema].
    Lopez L; Wierzbicka-Hainaut E; Villers A; Guillet G
    Ann Dermatol Venereol; 2009 Apr; 136(4):330-6. PubMed ID: 19361699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleromyxedema (Arndt - Gottron Syndrome) Developing Under Tenofovir Treatment for Hepatitis B: Unique Presentation in a Bulgarian Patient!
    Temelkova I; Patterson JW; Tchernev G
    Open Access Maced J Med Sci; 2019 Mar; 7(5):782-785. PubMed ID: 30962839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arndt-Gottron scleromyxedema and associated phenomena].
    Lang E; Zabel M; Schmidt H
    Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin.
    Dolenc-Voljč M; Jurčić V; Hočevar A; Tomšič M
    Case Rep Dermatol; 2013; 5(3):309-15. PubMed ID: 24348379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arndt-Gottron scleromyxoedema: successful therapy with intravenous immunoglobulins.
    Gholam P; Hartmann M; Enk A
    Br J Dermatol; 2007 Nov; 157(5):1058-60. PubMed ID: 17854360
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema.
    Rongioletti F; Rebora A
    J Am Acad Dermatol; 2001 Feb; 44(2):273-81. PubMed ID: 11174386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Efficacy of Treatment with Intravenous Immunoglobulin in Scleromyxedema.
    Baglama Š; Trčko K
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):24-28. PubMed ID: 32650847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful therapy of scleromyxoedema Arndt-Gottron with low-dose intravenous immunoglobulin.
    Körber A; Franckson T; Grabbe S; Dissemond J
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):553-4. PubMed ID: 17373996
    [No Abstract]   [Full Text] [Related]  

  • 12. [Internal disease findings in Arndt-Gottron scleromyxedema].
    Lang E; Goos M
    Dtsch Med Wochenschr; 1986 May; 111(21):820-3. PubMed ID: 3084193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleromyxedema.
    Hoffmann JHO; Enk AH
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1449-1467. PubMed ID: 33373143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin.
    Kim S; Park TH; Lee SM; Kim YH; Cho MK; Whang KU; Kim HS
    Dermatol Ther; 2020 May; 33(3):e13378. PubMed ID: 32250023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrete Papular Lichen Myxedematosus and Scleromyxedema with Hypothyroidism: A Report of Two Cases.
    Shenoy A; Steixner J; Beltrani V; Gottlieb A
    Case Rep Dermatol; 2019; 11(1):64-70. PubMed ID: 31011315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scleromyxedema].
    Neufeld M; Sunderkötter C; Moritz RKC
    Hautarzt; 2018 Nov; 69(11):916-921. PubMed ID: 30135969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature.
    Fleming KE; Virmani D; Sutton E; Langley R; Corbin J; Pasternak S; Walsh NM
    J Cutan Pathol; 2012 May; 39(5):508-17. PubMed ID: 22515222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleromyxedema in a patient with thyroid disease: an atypical case or a case for revised criteria?
    Hazan E; Griffin TD; Jabbour SA; Keller MS
    Cutis; 2020 Jan; 105(1):E6-E10. PubMed ID: 32074156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease.
    Rongioletti F
    Semin Cutan Med Surg; 2006 Jun; 25(2):100-4. PubMed ID: 16908401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized papular and sclerodermoid eruption: scleromyxedema.
    Serdar ZA; Altunay IK; Yasar SP; Erfan GT; Gunes P
    Indian J Dermatol Venereol Leprol; 2010; 76(5):592. PubMed ID: 20827020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.